CNOT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.010000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.423400E-01
Normal-vs-Stage2
4.509800E-01
Normal-vs-Stage3
1.756050E-01
Normal-vs-Stage4
7.184000E-01
Stage1-vs-Stage2
7.268600E-01
Stage1-vs-Stage3
1.025000E-01
Stage1-vs-Stage4
1.276420E-01
Stage2-vs-Stage3
4.897700E-02
Stage2-vs-Stage4
9.702200E-02
Stage3-vs-Stage4
4.490400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.879200E-01
Normal-vs-AfricanAmerican
9.272200E-01
Normal-vs-Asian
2.533600E-01
Caucasian-vs-AfricanAmerican
1.540810E-01
Caucasian-vs-Asian
4.448000E-01
AfricanAmerican-vs-Asian
9.895500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.357000E-01
Normal-vs-Female
3.899600E-01
Male-vs-Female
6.382800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.154800E-01
Normal-vs-Age(41-60Yrs)
6.707000E-01
Normal-vs-Age(61-80Yrs)
3.244400E-01
Normal-vs-Age(81-100Yrs)
3.516600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.462600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.802600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.815200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.194000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.325800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.264600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.524200E-01
Normal-vs-Daily Drinker
3.985200E-01
Normal-vs-Weekly Drinker
1.567170E-01
Normal-vs-Occasional Drinker
8.887800E-01
Normal-vs-Social Drinker
6.325000E-01
Non Drinker-vs-Daily Drinker
7.094200E-01
Non Drinker-vs-Weekly Drinker
5.063800E-01
Non Drinker-vs-Occasional Drinker
2.464000E-02
Non Drinker-vs-Social Drinker
2.132200E-01
Daily Drinker-vs-Weekly Drinker
3.750600E-01
Daily Drinker-vs-Occasional Drinker
1.007960E-01
Daily Drinker-vs-Social Drinker
4.326200E-01
Weekly Drinker-vs-Occasional Drinker
8.119300E-03
Weekly Drinker-vs-Social Drinker
9.327700E-02
Occasional Drinker-vs-Social Drinker
4.349200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.557800E-02
Normal-vs-Grade 2
7.904800E-03
Normal-vs-Grade 3
2.075900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.237380E-01
Grade 1-vs-Grade 3
7.682900E-03
Grade 1-vs-Grade 4
6.557800E-02
Grade 2-vs-Grade 3
7.219500E-02
Grade 2-vs-Grade 4
7.904800E-03
Grade 3-vs-Grade 4
2.075900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.564600E-01
Normal-vs-NonDiabetic
3.533200E-01
Diabetic-vs-NonDiabetic
4.576200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.503200E-01
Normal-vs-NoPancreatitis
2.987800E-01
Pancreatitis-vs-NoPancreatitis
2.279600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.628000E-01
Normal-vs-N1
4.240000E-01
N0-vs-N1
7.685200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.034200E-01
Normal-vs-TP53-NonMutant
5.167800E-01
TP53-Mutant-vs-TP53-NonMutant
1.618120E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
